Association between thyroid hormones and renal function in patients with chronic kidney disease: A hospital-based cross-sectional study among Nigerians

A. Adelakun, Akhigbe R. Eghoghosoa, L. Ajayi, A. Ajayi
{"title":"Association between thyroid hormones and renal function in patients with chronic kidney disease: A hospital-based cross-sectional study among Nigerians","authors":"A. Adelakun, Akhigbe R. Eghoghosoa, L. Ajayi, A. Ajayi","doi":"10.4103/njecp.njecp_2_22","DOIUrl":null,"url":null,"abstract":"Background: A seemingly exciting link has been reported to exist between thyroid state and renal function, thus establishing a thyroid–renal axis. However, findings from studies aimed at evaluating this axis have not been consistent. Therefore, we hypothesized that estimated glomerular filtration rate (eGFR), a surrogate of incident chronic kidney disease (CKD), could be independently predicted by thyroid-stimulating hormone (TSH), free thyroxin (fT4), and free triiodothyronine (fT3). Materials and Methods: We compared the serum concentrations of TSH, fT4, and fT3 in patients with CKD after classifying them into stage III, stage IV, or end-stage renal disease based on the National Kidney Foundation Classification Criteria. Results: Our results showed that the concentrations of TSH, fT4, and fT3 were comparable across the different stages of CKD. Findings from the study also indicated that thyroid hormones were not associated with CKD, nor were they predictors of CKD development. Conclusion: The present study demonstrates that TSH, fT4, and fT3 are not effective risk factors that are independently associated with declined eGFR in patients with CKD. Our findings also revealed that these hormones are not useful tools in the early detection of CKD.","PeriodicalId":19420,"journal":{"name":"Nigerian Journal of Experimental and Clinical Biosciences","volume":"26 1","pages":"29 - 33"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian Journal of Experimental and Clinical Biosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/njecp.njecp_2_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A seemingly exciting link has been reported to exist between thyroid state and renal function, thus establishing a thyroid–renal axis. However, findings from studies aimed at evaluating this axis have not been consistent. Therefore, we hypothesized that estimated glomerular filtration rate (eGFR), a surrogate of incident chronic kidney disease (CKD), could be independently predicted by thyroid-stimulating hormone (TSH), free thyroxin (fT4), and free triiodothyronine (fT3). Materials and Methods: We compared the serum concentrations of TSH, fT4, and fT3 in patients with CKD after classifying them into stage III, stage IV, or end-stage renal disease based on the National Kidney Foundation Classification Criteria. Results: Our results showed that the concentrations of TSH, fT4, and fT3 were comparable across the different stages of CKD. Findings from the study also indicated that thyroid hormones were not associated with CKD, nor were they predictors of CKD development. Conclusion: The present study demonstrates that TSH, fT4, and fT3 are not effective risk factors that are independently associated with declined eGFR in patients with CKD. Our findings also revealed that these hormones are not useful tools in the early detection of CKD.
慢性肾病患者甲状腺激素与肾功能的关系:尼日利亚医院横断面研究
背景:据报道,甲状腺状态和肾功能之间存在着一种看似令人兴奋的联系,从而建立了甲状腺-肾轴。然而,旨在评估这一轴的研究结果并不一致。因此,我们假设肾小球滤过率(eGFR)可以通过促甲状腺激素(TSH)、游离甲状腺素(fT4)和游离三碘甲状腺原氨酸(fT3)独立预测,作为慢性肾脏疾病(CKD)发病率的替代指标。材料和方法:我们根据国家肾脏基金会的分类标准,将CKD患者分为III期、IV期或终末期肾脏疾病,比较了患者血清TSH、fT4和fT3的浓度。结果:我们的研究结果表明,TSH、fT4和fT3的浓度在CKD的不同阶段具有可比性。研究结果还表明,甲状腺激素与CKD无关,也不是CKD发展的预测因素。结论:本研究表明,TSH、fT4和fT3不是CKD患者eGFR下降的有效独立危险因素。我们的研究结果还表明,这些激素在CKD的早期检测中不是有用的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信